COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

A Multiple Testing Procedure for Clinical Trials

1979 • 3,139 citations

Analysis of Binary Data

2008 • 2,760 citations

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

1988 • 704 citations

Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial

2000 • 602 citations

Analysis of Binary Data (2nd ed.).

1990 • 510 citations

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

1999 • 458 citations

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1993 • 394 citations

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

1986 • 337 citations

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.

1989 • 325 citations

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.

1997 • 317 citations

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

1995 • 302 citations

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.

1993 • 155 citations

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.

1989 • 128 citations

1064 Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study

1995 • 13 citations

1086 A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer

1995 • 11 citations